Glanbia PLC (GL9) - Total Liabilities
Based on the latest financial reports, Glanbia PLC (GL9) has total liabilities worth €1.85 Billion EUR (≈ $2.16 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Glanbia PLC - Total Liabilities Trend (1985–2024)
This chart illustrates how Glanbia PLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Glanbia PLC Competitors by Total Liabilities
The table below lists competitors of Glanbia PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Olav Thon Eien
OL:OLT
|
Norway | Nkr32.70 Billion |
|
GZ Port
SHG:601228
|
China | CN¥28.08 Billion |
|
Navin Fluorine International Limited
NSE:NAVINFLUOR
|
India | Rs20.42 Billion |
|
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX
|
USA | $2.78 Billion |
|
Nelnet Inc
NYSE:NNI
|
USA | $10.29 Billion |
|
Maximus Inc
NYSE:MMS
|
USA | $2.49 Billion |
|
Garden Reach Shipbuilders & Engineers Limited
NSE:GRSE
|
India | Rs86.88 Billion |
|
Pan African Resources PLC
JSE:PAN
|
South Africa | ZAC469.72 Million |
Liability Composition Analysis (1985–2024)
This chart breaks down Glanbia PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.90 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Glanbia PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Glanbia PLC (1985–2024)
The table below shows the annual total liabilities of Glanbia PLC from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.80 Billion ≈ $2.11 Billion |
+8.11% |
| 2023-12-31 | €1.67 Billion ≈ $1.95 Billion |
-16.33% |
| 2022-12-31 | €1.99 Billion ≈ $2.33 Billion |
+5.53% |
| 2021-12-31 | €1.89 Billion ≈ $2.21 Billion |
+29.84% |
| 2020-12-31 | €1.45 Billion ≈ $1.70 Billion |
-14.44% |
| 2019-12-31 | €1.70 Billion ≈ $1.99 Billion |
+12.55% |
| 2018-12-31 | €1.51 Billion ≈ $1.76 Billion |
+37.07% |
| 2017-12-31 | €1.10 Billion ≈ $1.29 Billion |
-25.67% |
| 2016-12-31 | €1.48 Billion ≈ $1.73 Billion |
-6.69% |
| 2015-12-31 | €1.59 Billion ≈ $1.86 Billion |
+22.02% |
| 2014-12-31 | €1.30 Billion ≈ $1.52 Billion |
+24.01% |
| 2013-12-31 | €1.05 Billion ≈ $1.23 Billion |
-15.41% |
| 2012-12-31 | €1.24 Billion ≈ $1.45 Billion |
-6.39% |
| 2011-12-31 | €1.33 Billion ≈ $1.55 Billion |
+10.21% |
| 2010-12-31 | €1.20 Billion ≈ $1.41 Billion |
+6.59% |
| 2009-12-31 | €1.13 Billion ≈ $1.32 Billion |
-8.07% |
| 2008-12-31 | €1.23 Billion ≈ $1.43 Billion |
+30.30% |
| 2007-12-31 | €941.72 Million ≈ $1.10 Billion |
-2.14% |
| 2006-12-31 | €962.29 Million ≈ $1.13 Billion |
+14.13% |
| 2005-12-31 | €843.14 Million ≈ $985.72 Million |
+36.38% |
| 2004-12-31 | €618.24 Million ≈ $722.79 Million |
+6.54% |
| 2003-12-31 | €580.30 Million ≈ $678.43 Million |
-8.63% |
| 2002-12-31 | €635.08 Million ≈ $742.47 Million |
-23.33% |
| 2001-12-31 | €828.33 Million ≈ $968.41 Million |
-6.93% |
| 2000-12-31 | €890.02 Million ≈ $1.04 Billion |
-9.37% |
| 1999-12-31 | €982.05 Million ≈ $1.15 Billion |
-10.61% |
| 1998-12-31 | €1.10 Billion ≈ $1.28 Billion |
-5.25% |
| 1997-12-31 | €1.16 Billion ≈ $1.36 Billion |
+221.17% |
| 1996-12-31 | €361.02 Million ≈ $422.07 Million |
-21.32% |
| 1995-12-31 | €458.87 Million ≈ $536.47 Million |
+0.72% |
| 1994-12-31 | €455.58 Million ≈ $532.62 Million |
+25.09% |
| 1993-12-31 | €364.19 Million ≈ $425.78 Million |
+27.82% |
| 1992-12-31 | €284.93 Million ≈ $333.11 Million |
+37.30% |
| 1991-12-31 | €207.52 Million ≈ $242.61 Million |
+8.65% |
| 1990-12-31 | €191.00 Million ≈ $223.30 Million |
+58.87% |
| 1989-12-31 | €120.22 Million ≈ $140.55 Million |
+72.55% |
| 1988-12-31 | €69.67 Million ≈ $81.46 Million |
+24.67% |
| 1987-12-31 | €55.89 Million ≈ $65.34 Million |
-10.72% |
| 1986-12-31 | €62.60 Million ≈ $73.18 Million |
+6.85% |
| 1985-12-31 | €58.59 Million ≈ $68.49 Million |
-- |
About Glanbia PLC
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes produ… Read more